1. TIM-3 Is a Potential Immune Checkpoint Target in Cats with Mammary Carcinoma
   Sofia Valente et al, 2023, Cancers CrossRef
2. Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target
   Minpu Zhang et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
3. Pattern Analysis of Serum Galectins-1, -3, and -9 in Breast Cancer
   Avery Funkhouser et al, 2023, Cancers CrossRef
4. Soluble TIM-3 as a biomarker of progression and therapeutic response in cancers and other of human diseases
   Christian Bailly et al, 2023, Biochemical Pharmacology CrossRef
5. Killer instincts: natural killer cells as multifactorial cancer immunotherapy
   Sarah Nersesian et al, 2023, Frontiers in Immunology CrossRef